000 | 01993 a2200565 4500 | ||
---|---|---|---|
005 | 20250515160755.0 | ||
264 | 0 | _c20090813 | |
008 | 200908s 0 0 eng d | ||
022 | _a1432-0851 | ||
024 | 7 |
_a10.1007/s00262-009-0672-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGedye, Craig | |
245 | 0 | 0 |
_aCancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. _h[electronic resource] |
260 |
_bCancer immunology, immunotherapy : CII _cOct 2009 |
||
300 |
_a1635-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAC133 Antigen |
650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
650 | 0 | 4 | _aColony-Forming Units Assay |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
650 | 0 | 4 |
_aHLA-A2 Antigen _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aMembrane Proteins _ximmunology |
650 | 0 | 4 |
_aPeptide Fragments _ximmunology |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
700 | 1 | _aQuirk, Juliet | |
700 | 1 | _aBrowning, Judy | |
700 | 1 | _aSvobodová, Suzanne | |
700 | 1 | _aJohn, Thomas | |
700 | 1 | _aSluka, Pavel | |
700 | 1 | _aDunbar, P Rod | |
700 | 1 | _aCorbeil, Denis | |
700 | 1 | _aCebon, Jonathan | |
700 | 1 | _aDavis, Ian D | |
773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 58 _gno. 10 _gp. 1635-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-009-0672-0 _zAvailable from publisher's website |
999 |
_c18664670 _d18664670 |